What is Quibim?
Quibim is at the forefront of medical imaging analysis, providing an AI-first approach to detect pathologies and track treatment efficacy through quantitative imaging biomarkers. Their flagship product, Quibim Precision®, is a comprehensive whole-body imaging ecosystem utilized by leading research teams worldwide. The company's technology supports a wide array of applications, from early disease detection to monitoring novel treatment outcomes, across all body parts and imaging modalities. This focus on precise, AI-driven insights positions Quibim as a key innovator in the health-tech sector.
How much funding has Quibim raised?
Quibim has raised a total of $50M across 1 funding round:
Series A
$50M
Series A (2025): $50M with participation from UI Investissement, Asabys Partners, and GoHub Ventures
Key Investors in Quibim
UI Investissement
UI Investissement is a French investment firm dedicated to supporting the growth of small and medium businesses. They provide smart capital and strategic support to privately held companies, focusing on helping them achieve their full potential through deep local market understanding.
Asabys Partners
Asabys Partners is a Barcelona-based investment firm specializing in breakthrough innovations within the healthcare and life sciences sectors. They invest in transformative technologies aimed at improving patient outcomes and collaborate closely with portfolio companies to provide expertise and support.
GoHub Ventures
GoHub Ventures is an early-stage venture capital fund that backs founders developing B2B software and digital health solutions. They offer long-term capital and hands-on support, with a particular interest in artificial intelligence and preventive care.
What's next for Quibim?
With its recent major strategic investment, Quibim is poised for accelerated growth and further development of its AI-driven medical imaging analysis platform. The company's commitment to quantitative imaging biomarkers and its global reach suggest a strategic focus on expanding its market penetration and enhancing its product offerings. Future endeavors will likely involve deeper integration of AI capabilities to refine diagnostic accuracy and treatment monitoring, solidifying its position as a leader in the health-tech landscape and potentially exploring new therapeutic areas or research collaborations.
See full Quibim company page
